ADD CONDITION

items per page

Labella Linimento Obrero

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredients
  • Menthol, Unspecified Form 20 mg/1 mL
  • Capsaicin 0.25 mg/1 mL
  • Methyl Salicylate 100 mg/1 mL
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2013
Label revision date
November 6, 2015
Active ingredients
  • Menthol, Unspecified Form 20 mg/1 mL
  • Capsaicin 0.25 mg/1 mL
  • Methyl Salicylate 100 mg/1 mL
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2013
Label revision date
November 6, 2015
Manufacturer
Golden Sun Inc DBA Newhall Laboratories
Registration number
part346
NDC root
31774-8005

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

LA BELLA™ is a pain-relieving cream known as LINIMENTO OBRERO, which contains Chile extract. It is designed to temporarily relieve minor aches and pains associated with muscles and joints, making it a helpful option for those seeking comfort from everyday discomfort.

With a net weight of 8 fluid ounces (236 ml), this cream can be easily applied to the affected areas to provide soothing relief. Whether you're dealing with muscle soreness or joint discomfort, LA BELLA™ aims to support your well-being.

Uses

You can use this medication to temporarily relieve minor aches and pains in your muscles and joints. It's designed to help you feel more comfortable when you're experiencing these types of discomfort.

Rest assured, there are no concerns about teratogenic effects (which means it won't cause birth defects) associated with this medication. This makes it a safer option for those who may be pregnant or planning to become pregnant.

Dosage and Administration

It's important to use this medication only as directed by your healthcare provider. If you are an adult or a child aged 2 years or older, you can apply it to the affected area up to 3 to 4 times a day. Make sure to follow the recommended frequency to ensure safety and effectiveness.

If your child is under 2 years old, it's best to consult a physician (doctor) before using this medication. They can provide guidance on the appropriate treatment for younger children. Always prioritize safety and follow the instructions provided by your healthcare professional.

What to Avoid

It's important to use this medication safely. You should avoid bandaging tightly, as this can cause complications. Additionally, do not apply the medication to wounds or broken skin, as this could lead to irritation or other issues. Following these guidelines will help ensure that you use the medication effectively and safely.

Side Effects

When using this product, it's important to be aware of some key safety information. This medication is for external use only, so keep it out of reach of children. If swallowed, seek medical help or contact a Poison Control Center right away. Avoid getting the product in your eyes, and do not apply it to wounds or broken skin. Additionally, do not bandage the area tightly. If your condition worsens or symptoms last longer than 7 days, stop using the product and consult a physician.

Warnings and Precautions

This product is intended for external use only, so please avoid swallowing it. If you or someone else accidentally swallows it, seek medical help or contact a Poison Control Center right away. Keep this and all medications out of the reach of children to prevent any accidental ingestion.

Be cautious to avoid contact with your eyes, and do not apply the product to wounds or broken skin. It's important not to bandage the area tightly after application. If your condition worsens or if symptoms last longer than 7 days, stop using the product and consult your doctor for further advice.

Overdose

If you or someone else has swallowed too much of this medication, it’s important to seek medical help right away. You can contact a Poison Control Center for guidance on what to do next.

Signs of an overdose can vary, but they may include unusual symptoms that require immediate attention. Always err on the side of caution and get help if you suspect an overdose has occurred. Your health and safety are the top priority.

Pregnancy Use

While there are no specific warnings or precautions regarding the use of LaBella Linimento Obrero during pregnancy, it's important to note that the information provided does not indicate whether the product is contraindicated (not recommended) for pregnant individuals or if there are any risks to the developing fetus. Additionally, there are no dosage modifications or special precautions mentioned for those who are pregnant.

As always, if you are pregnant or planning to become pregnant, it's best to consult with your healthcare provider before using any new products to ensure they are safe for you and your baby.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding nursing mothers or lactation in the information provided. This means that, based on the available data, there are no known risks associated with breastfeeding while using this medication. However, it's always a good idea to consult with your healthcare provider if you have any concerns or questions about your specific situation.

Pediatric Use

It's important to keep this medication and all other drugs out of the reach of children. If a child accidentally swallows it, seek medical help or contact a Poison Control Center right away.

For children aged 2 years and older, you can apply the medication to the affected area up to 3 to 4 times a day. However, if your child is under 2 years old, it's essential to consult a physician (doctor) before use. Always prioritize safety and follow these guidelines to ensure your child's well-being.

Geriatric Use

While there is no specific information about how this medication should be used by older adults, it’s important to approach any new treatment with caution. If you or a loved one is an older adult, it’s wise to discuss any potential risks or concerns with your healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken.

Always keep in mind that older adults may have different responses to medications, so regular check-ins with your doctor can ensure safety and effectiveness.

Renal Impairment

It appears that there is no specific information regarding renal impairment (kidney problems) in the provided text. Therefore, there are no guidelines, dosage adjustments, or monitoring instructions to share for patients with kidney issues. If you have concerns about how your kidney health may affect your treatment, it's important to discuss this with your healthcare provider for personalized advice and recommendations.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard dosing and monitoring practices apply, but you should always consult your healthcare provider for personalized advice. They can help ensure that any medications you take are safe and effective for your liver health.

Make sure to keep your doctor informed about your liver condition, as they may want to monitor your liver function regularly to ensure everything is working well. Your health and safety are the top priority, so don’t hesitate to ask questions or express any concerns you may have.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that, based on the available information, this medication is not known to interfere with other drugs or tests. However, every individual is different, and your healthcare provider can help ensure that your treatment plan is safe and effective for you. Always share your complete list of medications and any tests you may undergo to avoid any potential issues.

Storage and Handling

To ensure the best quality and safety of your product, store it at room temperature, away from direct light. It's important to keep the container tightly closed when not in use to prevent contamination. Once you open the container, be sure to discard any remaining product after use to maintain safety and effectiveness. Following these guidelines will help you use the product safely and effectively.

Additional Information

You should apply this medication topically to the affected area, using it no more than 3 to 4 times a day if you are an adult or a child aged 2 years or older. If the patient is under 2 years old, it's important to consult a physician before use. There are no additional details available regarding laboratory tests, abuse potential, or postmarketing experiences related to this medication.

FAQ

What is LA BELLA™?

LA BELLA™ is a pain-relieving cream known as LINIMENTO OBRERO, which contains Chile extract.

What does LA BELLA™ do?

It temporarily relieves minor aches and pains of muscles and joints.

How should I use LA BELLA™?

Apply to the affected area not more than 3 to 4 times daily for adults and children 2 years of age or older. Consult a physician for children under 2 years.

Are there any contraindications for using LA BELLA™?

No specific contraindications are mentioned for LA BELLA™.

What precautions should I take when using LA BELLA™?

For external use only. Avoid contact with eyes, do not bandage tightly, and do not apply to wounds or broken skin.

What should I do if I swallow LA BELLA™?

Get medical help or contact a Poison Control Center immediately if swallowed.

Can I use LA BELLA™ during pregnancy?

There are no specific warnings or contraindications regarding the use of LA BELLA™ during pregnancy.

Is LA BELLA™ safe for nursing mothers?

The insert does not provide specific warnings or recommendations for nursing mothers.

How should I store LA BELLA™?

Store at room temperature, protect from light, and keep the container tightly closed. Discard after opening.

What should I do if my condition worsens while using LA BELLA™?

If your condition worsens or symptoms persist for more than 7 days, discontinue use and consult a physician.

Packaging Info

Below are the non-prescription pack sizes of Labella Linimento Obrero (capsaicin, menthol, unspecified form, and methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Labella Linimento Obrero.
Details

Drug Information (PDF)

This file contains official product information for Labella Linimento Obrero, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

LA BELLA™ LINIMENTO OBRERO is a pain-relieving cream formulated with Chile extract. This topical preparation is designed to alleviate minor aches and pains. The product is presented in a net weight of 8 fluid ounces (236 ml).

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be used only as directed. For adults and children aged 2 years and older, it is recommended to apply the product to the affected area no more than 3 to 4 times daily. For children under 2 years of age, it is advised to consult a physician prior to use.

Contraindications

The product should not be used in the following situations:

Tight bandaging is contraindicated, as it may lead to compromised circulation. Additionally, application to wounds or broken skin is prohibited due to the risk of irritation or infection.

Warnings and Precautions

For external use only. It is imperative to keep this and all other medications out of the reach of children to prevent accidental ingestion. In the event of swallowing the product, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Healthcare professionals should advise patients to avoid contact with the eyes, as this may lead to irritation or injury. Additionally, it is crucial not to bandage the area tightly after application, as this may exacerbate potential adverse effects.

The product should not be applied to wounds or broken skin, as this could increase the risk of systemic absorption and adverse reactions. If the condition worsens or if symptoms persist beyond 7 days, patients are advised to discontinue use and consult a physician for further evaluation and management.

Side Effects

Patients should be aware of the following warnings associated with the use of this product. It is intended for external use only and must be kept out of the reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact with a Poison Control Center is advised.

When using this product, patients should avoid contact with the eyes and should not bandage the area tightly. It is also important not to apply the product to wounds or broken skin. If the condition worsens or if symptoms persist for more than 7 days, patients are advised to discontinue use and consult a physician.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Labella Linimento Obrero (capsaicin, menthol, unspecified form, and methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Labella Linimento Obrero.
Details

Pediatric Use

Pediatric patients should be closely monitored to ensure the safe use of this medication. It is essential to keep this and all other drugs out of the reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or a Poison Control Center should be contacted.

For pediatric patients aged 2 years and older, the recommended application is to the affected area no more than 3 to 4 times daily. However, for children under 2 years of age, it is advised to consult a physician prior to use to ensure safety and appropriateness of treatment.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There are no specific warnings or precautions regarding the use of LaBella Linimento Obrero during pregnancy. The prescribing information does not indicate whether the product is contraindicated in pregnant patients or if there are any associated risks to the fetus. Additionally, no dosage modifications or special precautions for individuals who are pregnant are provided. Healthcare professionals should consider the absence of data when advising women of childbearing potential regarding the use of this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this medication in lactating mothers. Additionally, there are no known data on excretion in breast milk or effects on breastfed infants. Healthcare professionals should consider the absence of specific guidance when advising lactating mothers about the use of this medication.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients that the product is intended for external use only. It is crucial to emphasize the importance of keeping this and all other medications out of the reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical assistance or contact a Poison Control Center immediately.

Patients should be cautioned to avoid contact with the eyes, as this may lead to irritation or injury. Additionally, they should be informed not to bandage the area tightly after application, as this could exacerbate potential side effects. It is important to advise against applying the product to wounds or broken skin to prevent further complications.

Healthcare providers should also inform patients that if their condition worsens or if symptoms persist for more than 7 days, they should discontinue use of the product and consult a physician for further evaluation and guidance.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers. It should be stored at room temperature, ensuring that it is protected from light exposure. The container must be kept tightly closed to maintain the integrity of the product. Additionally, it is important to discard the product after opening to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 2 years and older. For children under 2 years of age, consultation with a physician is advised prior to use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Labella Linimento Obrero, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Labella Linimento Obrero, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.